When is Lugol still necessary in 2020?

Steffi E.M. van de Ven; Arjun D. Koch

doi:10.1055/a-1216-1864

Endoscopy International Open, Table of Contents

CC BY-NC-ND 4.0 · Endosc Int Open 2020; 08(10): E1478-E1480
DOI: 10.1055/a-1216-1864

Editorial

When is Lugol still necessary in 2020?

Authors

Steffi E.M. van de Ven

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands
Arjun D. Koch

Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands

Abstract

Full Text

References

References
1 Goda K, Dobashi A, Yoshimura N. et al. Narrow-Band imaging magnifying endoscopy versus lugol chromoendoscopy with pink-color sign assessment in the diagnosis of superficial esophageal squamous neoplasms: a randomised noninferiority trial. Gastroenterol Res Pract 2015; 2015: 639462
2 Voegeli R. Schillerʼs iodine test in the diagnosis of esophageal diseases. Preliminary report. Pract Otorhinolaryngol (Basel) 1966; 28: 230-239
3 Bugter O, van de Ven SEM, Hardillo JA. et al. Early detection of esophageal second primary tumors using Lugol chromoendoscopy in patients with head and neck cancer: A systematic review and meta-analysis. Head Neck 2019; 41: 1122-1130
4 Inoue H, Rey JF, Lightdale C. Lugol chromoendoscopy for esophageal squamous cell cancer. Endoscopy 2001; 33: 75-79
5 Mori M, Adachi Y, Matsushima T. et al. Lugol staining pattern and histology of esophageal lesions. Am J Gastroenterol 1993; 88: 701-705
6 Lopes AB, Fagundes RB. Esophageal squamous cell carcinoma – precursor lesions and early diagnosis. World J Gastrointest Endosc 2012; 4: 9-16
7 Dubuc J, Legoux J-L, Winnock M. et al. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 french endoscopy centers. Endoscopy 2006; 38: 690-695
8 Gotoda T, Kanzaki H, Okamoto Y. et al. Tolerability and efficacy of the concentration of iodine solution during esophageal chromoendoscopy: a double-blind randomized controlled trial. Gastrointest Endosc 2020; 91: 763-770
9 Wang CH, Lee YC, Wang CP. et al. Use of transnasal endoscopy for screening of esophageal squamous cell carcinoma in high-risk patients: yield rate, completion rate, and safety. Digest Endosc 2014; 26: 24-31
10 Gono K, Obi T, Yamaguchi M. et al. Appearance of enhanced tissue features in narrow-band endoscopic imaging. J Biomed Opt 2004; 9: 568-577
11 Yoshida T, Inoue H, Usui S. et al. Narrow-band imaging system with magnifying endoscopy for superficial esophageal lesions. Gastrointest Endosc 2004; 59: 288-295
12 Morita FH, Bernardo WM, Ide E. et al. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. BMC Cancer 2017; 17: 54
13 Ishihara R, Inoue T, Uedo N. et al. Significance of each narrow-band imaging finding in diagnosing squamous mucosal high-grade neoplasia of the esophagus. J Gastroenterol Hepatol 2010; 25: 1410-1415
14 Costa-Santos MariaPia, Ferreira AlexandreOliveira, Mouradides Christina. et al. Is Lugol necessary for endoscopic resection of esophageal squamous cell neoplasia?. Endosc Int Open 2020; 08: E1471-E1477
15 Ahmad OF, Soares AS, Mazomenos E. et al. Artificial intelligence and computer-aided diagnosis in colonoscopy: current evidence and future directions. Lancet Gastroenterol Hepatol 2019; 4: 71-80
16 Ding Z, Shi H, Zhang H. et al. Gastroenterologist-level identification of small-bowel diseases and normal variants by capsule endoscopy using a deep-learning model. Gastroenterology 2019; 157: 1044-1054 e1045